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Evaluation of Antibiotic Prescribing Patterns for                        
Community Acquired Pneumonia
Gregory Schaefer PharmD, Ann Wigton PharmD, BCPS, BCIDP
Inpatient Pharmacy Services, St. Cloud Hospital, St. Cloud, Minnesota
Introduction Evaluation
• Clinical guidelines recommend a total antibiotic length 
of therapy (LOT) of 5-7 days for community acquired 
pneumonia (CAP)1 
• Empiric therapy should include a respiratory 
fluoroquinolone or a combination of a β-lactam 
antibiotic plus azithromycin1
• An analysis of United States hospitals found the 
median CAP LOT (inpatient plus outpatient) was 
approximately 10 days2
• To evaluate duration of antibiotic therapy and 
prescribing patterns for non-ICU CAP at St 
Cloud Hospital, a tertiary community hospital
• Total LOT exceeded the 7 day breakpoint by 1.4 days 
with outpatient LOT as the major contributor to excess 
antibiotic days
• Prescribed antibiotic classes were consistent with 
guidelines and most frequently included 3rd generation 
cephalosporins, tetracyclines, macrolides, and 
fluoroquinolones
• Limitations included unassessed antibiotic days prior 
to admission and outpatient CDI 
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Results
Purpose Conclusion
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Methods
Inclusion Criteria Exclusion Criteria
CAP hospitalization Hospitalized 30 days prior 
to index hospitalization
1◦ diagnosis of bacterial or 
unspecified pneumonia
Rehospitalized within three 
days after index discharge 
Age ≥ 18 years ICU admission
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72 Screened
22 Excluded
- 14 hospitalized 30 days prior
- 8 rehospitalized within 3 days
50 Included
• St. Cloud Hospital has an opportunity to improve 
CAP antibiotic length of therapy by targeting 
outpatient prescribing patterns 
Total Antibiotic Length of Therapy in Days 
Prescribing calculations: Inpatient = days of antibiotic class / total days of therapy; Outpatient = prescriptions of antibiotic class / total number of prescriptions
*BL/BLIs = β-lactam/β-lactamase inhibitors
58%40%
3.6 Days
(43%)
2%
• IRB-approved, retrospective chart review of patients 
discharged with a diagnosis of CAP between 
January 1, 2018 and June 30, 2018
• Total LOT, inpatient LOT, outpatient LOT, antibiotics 
utilized, and inpatient Clostridioides difficile infection 
(CDI) were evaluated
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Antibiotic Prescribing Patterns
*
*
= CDI event documented for one patient treated for 7 days and one patient treated for 14 days  *
